Cargando…

Surrogate outcomes: experiences at the Common Drug Review

BACKGROUND: Surrogate outcomes are a significant challenge in drug evaluation for health technology assessment (HTA) agencies. The research objectives were to: identify factors associated with surrogate use and acceptability in Canada’s Common Drug Review (CDR) recommendations, and compare the CDR w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rocchi, Angela, Khoudigian, Shoghag, Hopkins, Rob, Goeree, Ron
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3866929/ https://www.ncbi.nlm.nih.gov/pubmed/24341379 http://dx.doi.org/10.1186/1478-7547-11-31

Ejemplares similares

Cost-effectiveness of the Aerobika* oscillating positive expiratory pressure device in the management of COPD exacerbations
por: Khoudigian-Sinani, Shoghag, et al.
Publicado: (2017)

A review of health utilities across conditions common in paediatric and adult populations
por: Tarride, Jean-Eric, et al.
Publicado: (2010)

Lorlatinib Effectiveness and Quality-of-Life in Patients with ALK-Positive NSCLC Who Had Failed Second-Generation ALK Inhibitors: Canadian Real-World Experience
por: Rupp, Martin, et al.
Publicado: (2023)

Economic burden of illness associated with diabetic foot ulcers in Canada
por: Hopkins, Robert B, et al.
Publicado: (2015)

Surrogate endpoints… Uncommon for a common man!
por: Kumar, Ashish
Publicado: (2019)

Identifying regulation with adversarial surrogates
por: Teichner, Ron, et al.
Publicado: (2023)

Surrogate outcomes in neurology, psychiatry, and psychopharmacology
por: Staner, Luc
Publicado: (2006)

Clinical outcomes: to be a surrogate or not to be ...?
por: Cameron, David
Publicado: (2007)

Oncology drug health technology assessment recommendations: Canadian versus UK experiences
por: Chabot, Isabelle, et al.
Publicado: (2014)

The relative efficacy of nine osteoporosis medications for reducing the rate of fractures in post-menopausal women
por: Hopkins, Robert B, et al.
Publicado: (2011)

Evaluating the evidence behind the surrogate measures included in the FDA's table of surrogate endpoints as supporting approval of cancer drugs
por: Gyawali, Bishal, et al.
Publicado: (2020)

A Literature Review of Economic Evaluations for a Neglected Tropical Disease: Human African Trypanosomiasis (“Sleeping Sickness”)
por: Sutherland, C. Simone, et al.
Publicado: (2015)

Statistical validation of surrogate outcome measures
por: Buyse, Marc
Publicado: (2011)

Debate: The slippery slope of surrogate outcomes
por: D'Agostino, Ralph B
Publicado: (2000)

Overview of Biomarkers and Surrogate Endpoints in Drug Development
por: Wagner, John A.
Publicado: (2002)

Use of surrogate outcomes in US FDA drug approvals, 2003–2012: a survey
por: Yu, Tsung, et al.
Publicado: (2015)

Surrogate biomarkers of outcome for wake-up ischemic stroke
por: Hervella, Pablo, et al.
Publicado: (2022)

Surrogate endpoints.
por: Ellenberg, S. S.
Publicado: (1993)

Evolution of health technology assessment: best practices of the pan-Canadian Oncology Drug Review
por: Rocchi, Angela, et al.
Publicado: (2015)

Surrogates are just surrogates, but helpful just the same
por: Fabian, Carol
Publicado: (2007)

The comparison of the commonly used surrogates for baseline renal function in acute kidney injury diagnosis and staging
por: Thongprayoon, Charat, et al.
Publicado: (2016)

An Evaluation of Commonly Used Surrogate Baseline Creatinine Values to Classify AKI During Acute Infection
por: Cooper, Daniel J., et al.
Publicado: (2021)

Emotional experiences in surrogate mothers: A qualitative study
por: Ahmari Tehran, Hoda, et al.
Publicado: (2014)

The premarket assessment of the cost-effectiveness of a predictive technology “Straticyte™” for the early detection of oral cancer: a decision analytic model
por: Khoudigian-Sinani, S., et al.
Publicado: (2017)

A method to determine if more than surrogate outcomes were improved: The EMR glitch experiment
por: Gill, Jennifer, et al.
Publicado: (2019)

Protocol for the development of SPIRIT and CONSORT extensions for randomised controlled trials with surrogate primary endpoints: SPIRIT-SURROGATE and CONSORT-SURROGATE
por: Manyara, Anthony Muchai, et al.
Publicado: (2022)

The Roles of DNA Demethylases in Triple-Negative Breast Cancer
por: Panjarian, Shoghag, et al.
Publicado: (2021)

The Creation of Surrogate Models for Fast Estimation of Complex Model Outcomes
por: Pruett, W. Andrew, et al.
Publicado: (2016)

Optimization of in vitro culture conditions of common carp germ cells for purpose of surrogate production
por: Xie, Xuan, et al.
Publicado: (2022)

Step Process for Selecting and Testing Surrogates and Indicators of Afrotemperate Forest Invertebrate Diversity
por: Uys, Charmaine, et al.
Publicado: (2010)

Simulating an emergency department: the importance of modeling the interactions between physicians and delegates in a discrete event simulation
por: Lim, Morgan E, et al.
Publicado: (2013)

Change in hypnotic sedative choice over time as a surrogate marker of improved performance
por: Hughes, T, et al.
Publicado: (2011)

Imaging as a surrogate marker of drug efficacy in cardiovascular disease
por: Tarkin, Jason M, et al.
Publicado: (2019)

Postural Body Sway as Surrogate Outcome for Myelopathy in Adrenoleukodystrophy
por: van Ballegoij, Wouter J. C., et al.
Publicado: (2020)

Inconsistent reporting of surrogate outcomes in randomised clinical trials: cohort study
por: la Cour, Jeppe Lerche, et al.
Publicado: (2010)

Preliminary Identification of Coping Profiles Relevant to Surrogate Decision Making in the ICU
por: Butler, Jorie M., et al.
Publicado: (2016)

Heterogeneity of surrogate outcome measures used in critical care studies: A systematic review
por: Verghis, Rejina, et al.
Publicado: (2023)

FDA Acceptance of Surrogate End Points for Cancer Drug Approval: 1992-2019
por: Chen, Emerson Y., et al.
Publicado: (2020)

The Reporting of Observational Clinical Functional Magnetic Resonance Imaging Studies: A Systematic Review
por: Guo, Qing, et al.
Publicado: (2014)

1H-NMR metabolomics-based surrogates to impute common clinical risk factors and endpoints
por: Bizzarri, D., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_v1se7g2hk8hlt8bupfb6vnaq29